News: Pharma

News: Pharma

Pharmaceutical Industry News, Drugs, Nutraceuticals, Vitamins, and Related

News: Pharma

News: Pharma
Pharmaceutical Industry News, Drugs, Nutraceuticals, Vitamins, and Related
Gary Donovitz

BioTE Medical Experts Unite at AMMG Regarding Health Benefits of Testosterone Therapy in Women

eNewsChannels NEWS: (IRVING, Texas) -- BioTE(R) Medical announces a forum of medical experts gathering before the Age Management Medicine Group (AMMG) to form consensus on testosterone therapy in women. The AMMG conference runs April 27-30, 2017 in Orlando, Florida.
C.diff. Awareness Conference

C Diff Foundation Announces Experts to Gather Nov. 9-10 in Las Vegas about Infection Clostridium difficile

eNewsChannels NEWS: (LAS VEGAS, Nev.) -- C Diff Foundation's 5th Annual International C.diff. Awareness Conference and Health EXPO will be hosted in Las Vegas, Nev. on November 9 & 10, 2017 at UNLV-Thomas and Mack Center. A panel of C. diff. survivors will join world-renowned experts delivering presentations on health care topics pertaining to the most common pathogen identified, a leading healthcare-associated infection (HAI) in U.S. hospitals alone: Clostridium difficile (C.diff.).
Dr Don Harte

Trump’s wrong attack on Opioid Epidemic questioned by healthcare provider

eNewsChannels NEWS: (CORTE MADERA, Calif.) -- Dr. Don Harte, chiropractic activist, says Trump's new panel, headed by Chris Christie, to deal with the opioid epidemic, is "philosophically and scientifically dead wrong." Dr. Harte declares, "The reason for this epidemic is clear. Orthopedists and other doctors freely prescribe Oxycontin, Fentanyl, Soma and other opioid drugs, get their patients addicted."
Paragon BioTeck Inc

Ruling by USPTO Affirms Patent Claim for Paragon BioTeck’s R-Phenylephrine Hydrochloride Formulation

eNewsChannels NEWS: (PORTLAND, Ore.,) -- Paragon BioTeck, Inc. announces a monumental ruling handed down by the United States Patent and Trademark Office (USPTO) affirming claims made by Paragon in the patent for its R-phenylephrine hydrochloride formulation. Paragon is a privately held pharmaceutical and medical device company specializing in the development and commercialization of ophthalmic pharmaceuticals, devices and therapies.

WHAT'S NEWS